14:45-14:52 | PK-6 | mRNA profiling of an AQP4-expressing human cell model identifies NF-κB and IL-6 pathway activation in neuromyelitis optica spectrum disorder
Sarah Brandl (Medical University of Innsbruck – Innsbruck, Austria)
14:52-14:59 | PK-37 | a series of CD21lo B cell subsets and B-helper T cell subsets are recruited to the cerebrospinal fluid in the acute phase of neuromyelitis optica.
Ryusei Nishigori (Kyoto University Graduate School of Medicine – Kyoto, Japan)
14:59-15:06 | PK-53 | Retinoic acid – associated protection of the area postrema in neuromyelitis optica spectrum disorder
Qian Yu (Medical University of Vienna – Vienna, Austria)
15:06-15:13 | PK-356 | Increase in Cytotoxic Eomes-Expressing Helper T cells Associated with Refractory Neuromyelitis Optica
Eiichiro Amano (National Institute of Neuroscience, National Center of Neurology and Psychiatry – Kodaira, Japan)